# FDA 483 - Milestone Pharmaceutiques Inc - November 19, 2024

Source: https://www.globalkeysolutions.net/records/483/milestone-pharmaceutiques-inc/14b2ec40-b625-45cb-99a3-051369423430

> FDA 483 for Milestone Pharmaceutiques Inc on November 19, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Milestone Pharmaceutiques Inc
- Inspection Date: 2024-11-19
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: Milestone Pharmaceuticals Inc. in Saint-Laurent was inspected by the FDA from November 11-19, 2024. The inspection identified a failure by the firm to notify the FDA about the for-cause termination of a clinical investigator from a study. This observation highlights a lapse in regulatory reporting requirements for clinical trials.

## Related Officers

- [Consumer Safety Officer/BIMO Investigator](https://www.globalkeysolutions.net/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)

Company: https://www.globalkeysolutions.net/companies/milestone-pharmaceutiques-inc/946fd5b7-58bc-4c3c-915c-c839a6f73273

Office: https://www.globalkeysolutions.net/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8